FLUOGUIDE A/S DK -1 (96X) - Cash Flow Conversion Efficiency
Based on the latest financial reports, FLUOGUIDE A/S DK -1 (96X) has a cash flow conversion efficiency ratio of -0.092x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-5.03 Million ≈ $-5.88 Million USD) by net assets (€54.53 Million ≈ $63.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see FLUOGUIDE A/S DK -1 market capitalisation for the company's overall valuation and market capitalisation.
FLUOGUIDE A/S DK -1 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how FLUOGUIDE A/S DK -1's cash flow conversion efficiency has evolved over time, based on yearly financial data.
FLUOGUIDE A/S DK -1 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of FLUOGUIDE A/S DK -1 ranked by their cash flow conversion efficiency. See how well can FLUOGUIDE A/S DK -1 service its debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WeGrow AG
DU:ZN2
|
N/A |
|
Broad Capital Acquisition Corp
NASDAQ:BRAC
|
0.008x |
|
Saehwa IMC Co Ltd
KO:145210
|
0.026x |
|
Clipper Realty Inc
NYSE:CLPR
|
-0.171x |
|
ADOLFO DOMINGUEZ
MC:ADZ
|
0.253x |
|
Rent.com.Au Ltd
AU:RNT
|
-0.200x |
|
Millie Seojae.
KQ:418470
|
0.040x |
|
Sambo Industrial
KQ:009620
|
-0.150x |
Annual Cash Flow Conversion Efficiency for FLUOGUIDE A/S DK -1 (2021–2025)
The table below shows the annual cash flow conversion efficiency of FLUOGUIDE A/S DK -1 from 2021 to 2025. View FLUOGUIDE A/S DK -1 (96X) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €54.53 Million ≈ $63.75 Million |
€-36.96 Million ≈ $-43.21 Million |
-0.678x | +46.37% |
| 2024-12-31 | €23.07 Million ≈ $26.97 Million |
€-29.15 Million ≈ $-34.08 Million |
-1.264x | +49.46% |
| 2023-12-31 | €12.72 Million ≈ $14.87 Million |
€-31.81 Million ≈ $-37.19 Million |
-2.501x | -112.36% |
| 2022-12-31 | €31.97 Million ≈ $37.37 Million |
€-37.65 Million ≈ $-44.01 Million |
-1.178x | -202.57% |
| 2021-12-31 | €38.70 Million ≈ $45.25 Million |
€-15.06 Million ≈ $-17.61 Million |
-0.389x | -- |
About FLUOGUIDE A/S DK -1
FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatmen… Read more